Top

Intensive Care Medicine

Published in:

01-06-2006 | Clinical Commentary

Avian influenza (H5N1): implications for intensive care

Authors: Pascale C. Gruber, Charles D. Gomersall, Gavin M. Joynt

Published in: Intensive Care Medicine | Issue 6/2006

Abstract

Background

As influenza A/H5N1 spreads around the globe the risk of an epidemic increases.

Discussion

Review of the cases of influenza A/H5N1 reported to date demonstrates that it causes a severe illness, with a high proportion of patients (63%) requiring advanced organ support. Of these approx. 68% develop multiorgan failure, at least 54% develop acute respiratory distress syndrome, and 90% die. Disease progression is rapid, with a median time from presentation to hospital to requirement for advanced organ support of only 2 days.

Conclusion

The infectious nature, severity and clinical manifestations of the disease and its potential for pandemic spread have considerable implications for intensive care in terms of infection control, patient management, staff morale and intensive care expansion.

Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638–1652CrossRefPubMed

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke KJ, Hudson LD, Lamy M, LeGall JR, Morris A, Spragg R, the Consensus Committee (1994) The American-European Consensus Conference on ARDS. Am J Respir Crit Care Med 149:818–824PubMed

Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S (2005) Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352:333–340CrossRefPubMed

Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, Mak KH, Lim W, Tam JS, Clarke M, Williams SG, Mounts AW, Bresee JS, Conn LA, Rowe T, Hu-Primmer J, Abernathy RA, Lu X, Cox NJ, Fukuda K (2000) Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 181:344–348CrossRefPubMed

Liem NT, Lim W, World Health Organization International Avian Influenza Investigation Team (2005) Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 11:210–215PubMed

Schultsz C, Dong VC, Chau NV, Le NT, Lim W, Thanh TT, Dolecek C, de Jong MD, Hien TT, Farrar J (2005) Avian influenza H5N1 and healthcare workers. Emerg Infect Dis 11:1158–1159PubMed

Buxton Bridges C, Kuehnert MJ, Hall CB (2003) Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37:1094–1101CrossRefPubMed

UK Health Departments (2005) Pandemic flu. UK influenza pandemic contingency plan (October 2005). Department of Health, London. Available at http://www.dh.gov.uk/assetRoot/04/12/17/44/04121744.pdf (accessed 20 February 2006)

MacFarlane JT, Lim WS (2005) Bird flu and pandemic flu. BMJ 331:975–976CrossRefPubMed

10.

Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, Nicholls JM, Chokephaibulkit K, Vanprapar N, Auewarakul P (2005) Influenza A H5N1 replication sites in humans. Emerg Infect Dis 11:1036–1041PubMed

11.

de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, Tran TH, Do QH, Farrar J (2005) Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352:686–691CrossRefPubMed

12.

Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y (2004) Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363:617–619CrossRefPubMed

13.

To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL, Tsang DN, Sung RY, Buckley TA, Tam JS, Cheng AF (2001) Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63:242–246CrossRefPubMed

14.

Yuen KY, Chan PKS, Peiris M, Tsang DNC, Que TL, Shortridge KF, Cheung PT, To WK, Ho ETF, Sung R (1998) Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467–471CrossRefPubMed

15.

Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY, Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353:1374–1385CrossRefPubMed

16.

Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, Auwanit W, Thawatsupha P, Chittaganpitch M, Saeng-Aroon S, Waicharoen S, Apisarnthanarak P, Storch GA, Mundy LM, Fraser VJ (2004) Atypical avian influenza (H5N1). Emerg Infect Dis 10:1321–1324PubMed

17.

Centers for Disease Control, Prevention (CDC) (2004) Cases of influenza A (H5N1)-Thailand, 2004. MMWR Morb Mortal Wkly Rep 53:100–103

18.

Chan PKS (2002) Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 34:S58–S64CrossRefPubMed

19.

Chokephaibulkit K, Uiprasertkul M, Puthavathana P, Chearskul P, Auewarakul P, Dowell SF, Vanprapar N (2005) A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J 24:162–166CrossRefPubMed

20.

Hien TT, Liem NT, Dung NT, San LT, Mai PP, Chau NV, Suu PT, Dong VC, Mai LTQ, Thi NT, Khoa DB, Phat LP, Truong NT, Long HT, Tung CV, Giang LT, Tho ND, Nga LH, Tien NTK, San LH, Tuan LV, Dolecek C, Thanh TT, de Jong M, Schultsz C, Cheng P, Lim W, Horby P, the World Health Organization International Avian Influenza Investigative Team, Farrar J (2004) Avian Influenza A (H5N1) in 10 Patients in Vietnam. N Engl J Med 350:1179–1188CrossRefPubMed

21.

Yu H, Shu Y, Hu S, Zhang H, Gao Z, Chen H, Dong J, Xu C, Zhang Y, Xiang N, Wang M, Guo Y, Cox N, Lim W, Li D, Wang Y, Yang W (2006) The first confirmed human case of avian influenza A (H5N1) in mainland China. Lancet 367:84

22.

Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KHL, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437:1108

23.

Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, Lochindarat S, Srisan P, Suwan P, Osotthanakorn Y, Anantasetagoon T, Kanjanawasri S, Tanupattarachai S, Weerakul J, Chaiwirattana R, Maneerattanaporn M, Poolsavathitikool R, Chokephaibulkit K, Apisarnthanarak A, Dowell SF (2005) Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 11:201–209PubMed

24.

de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353:2667–2672CrossRefPubMed

25.

Thorson A, Petzold M, Nguyen TK, Ekdahl K (2006) Is exposure to sick or dead poultry associated with flulike illness?: A population-based study from a rural area in Vietnam with outbreaks of highly pathogenic avian influenza. Arch Intern Med 166:119–123CrossRefPubMed

26.

Wong SS, Yuen KY (2006) Avian influenza virus infections in humans. Chest 129:156–68CrossRefPubMed

27.

He G, Massarella J, Ward P (1999) Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64–0802. Clin Pharmacokinet 37:471–484CrossRefPubMed

28.

Bugge JF (2001) Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45:929–934CrossRefPubMed

29.

Schmidt AC (2004) Antiviral therapy for influenza. A clinical and economic comparative review. Drugs 64:2031–2046CrossRefPubMed

30.

Yuen KY, Wong SS (2005) Human infection by avian influenza A H5N1. Hong Kong Med J 11:189–199PubMed

31.

Gomersall CD, Tai DYH, Shi L, Derrick JL, Goh MS, Buckley TA, Chua C, Ho KM, Raghavan GP, Ho OM, Lee LB, Joynt GM (2006) Expanding ICU facilities in an epidemic: recommendations based on experience from the SARS epidemic in Hong Kong and Singapore. Intensive Care Med DOI 10.1007/s00134-006-0134-5

32.

World Health Organization (2006) Avian Influenza, including Influenza A (H5N1), in humans: WHO interim infection control guidelines for health care facilities (9 February); available at http://www.who.int/csr/disease/avian_influenza/guidelines/infectioncontrol1/en/index.html (accessed 20 February 2006)

33.

Centers for Disease Control and Prevention (2004) Interim recommendations for infecton control in healthcare facilities caring for patients with known or suspected avian influenza; available at http://www.cdc.gov/flu/avian/professional/infect-control.htm (accessed 20 February 2006)

34.

Department of Health England, Health Protection Agency (2005) Guidance for pandemic influenza: infection control in hospitals and primary care settings. Health Protection Agency, London; available at http://www.dh.gov.uk/assetRoot/04/12/17/54/04121754.pdf (accessed 20 February 2006)

35.

Derrick JL, Gomersall CD (2005) Protecting healthcare staff from severe acute respiratory syndrome. A study of the filtration capacity of multiple surgical masks. J Hosp Infect 59:365–368CrossRefPubMed

36.

Kellogg WH, MacMillan G (1920) An experimental study of the efficacy of gauze face masks. Am J Public Health 10:34–42CrossRef

37.

Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRef

38.

National Heart Lung and Blood Institute ARDS Clinical Trials Network (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336CrossRef

39.

Brower RG, Morris A, MacIntyre N, Matthay MA, Hayden D, Thompson T, Clemmer T, Lanken PN, Schoenfeld D, ARDS Clinical Trials Network National Heart Lung and Blood Institute of Health (2003) Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med 31:2592–2597PubMedCrossRef

40.

Barbas CS, de Matos GF, Pincelli MP, da Rosa BE, Antunes T, de Barros JM, Okamoto V, Borges JB, Amato MB, de Carvalho CR (2005) Mechanical ventilation in acute respiratory failure: recruitment and high positive end-expiratory pressure are necessary. Cur Opin Crit Care 11:18–28CrossRef

41.

Peter JV, Moran JL, Phillips-Hughes J, Warn D (2002) Noninvasive ventilation in acute respiratory failure-a meta-analysis update. Crit Care Med 30:555–562CrossRefPubMed

42.

Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A (2003) Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 168:1438–1444CrossRefPubMed

43.

Antonelli M, Conti G, Moro ML, Esquinas A, Gonzalez-Diaz G, Confalonieri M, Pelaia P, Principi T, Gregoretti C, Beltrame F, Pennisi MA, Arcangeli A, Proietti R, Passariello M, Meduri GU (2001) Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 27:1718–1728CrossRefPubMed

44.

Lew TWK, Kwek TK, Tai D, Ernest A, Loo S, Singh K, Kwan KM, Chan Y, Yim CF, Bek SL, Kor AC, Yap WS, Chelliah YR, Lai YC, Goh SK (2003) Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 290:374–380CrossRefPubMed

45.

Gomersall CD, Joynt GM, Lam P, Li T, Yap F, Lam D, Buckley TA, Sung JJY, Hui DS, Antonio GE, Ahuja AT, Leung P (2004) Short term of outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 30:381–387CrossRefPubMed

46.

Fowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS, Stewart TE, for the Toronto SARS Critical Care Group (2003) Critically ill patients with severe acute respiratory syndrome. JAMA 290:367–373CrossRefPubMed

47.

Xiao ZL, Li YM, Chen RC, Li SY, Zhong SQ, Zhong NS (2003) A retrospective study of 78 patients with severe acute respiratory failure. Chin Med J 116:805–810PubMed

48.

Rubinson L, Nuzzo JB, Talmor DS, O'Toole T, Kramer BR, Inglesby TV, for the Working Group on Emergency Mass Critical Care (2005) Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: Recommendations of the Working Group on Emergency Mass Critical Care. Crit Care Med 33:2393–2403CrossRefPubMed

49.

Legislative Council Select Committee (2004) Legislative Council Select Committee to Inquire into the Handling of the Severe Acute Respiratory Syndrome Outbreak by the Government and the Hospital Authority. 161–187, Hong Kong; available at http://www.legco.gov.hk/yr03--04/english/sc/sc_sars/reports/ch10.pdf (accessed 20 February 2006)

50.

Joynt GM, Gomersall CD, Tan P, Lee A, Cheng AY, Wong ELY (2001) Prospective evaluation of patients refused admission to an intensive care unit-triage, futility and outcome. Intensive Care Med 27:1459–1465CrossRefPubMed

Title: Avian influenza (H5N1): implications for intensive care
Authors: Pascale C. Gruber
Charles D. Gomersall
Gavin M. Joynt
Publication date: 01-06-2006
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 6/2006
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-006-0148-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Avian influenza (H5N1): implications for intensive care

Abstract

Background

Discussion

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Discussion

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2006

Weaning failure from cardiovascular origin

Prevention strategies in patients at high-risk for Candida infections: data from a neonatal intensive care setting

Ethical, political, and social aspects of high-technology medicine: Eos and Care

Pleural drain malposition

Significant cognitive dysfunction in non-delirious patients identified during and persisting following critical illness

Cytokeratin 19 fragments in patients with acute lung injury: a preliminary observation